ScholarIQanswers from OpenAlex

Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis

PaperCitations, authors & open-access status

Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis have?

ScholarIQcitation count

Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis has 60 citations in the OpenAlex counts ScholarIQ stores.

When was Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis published?

ScholarIQyear

Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis has 2012 year in the ScholarIQ index.

What is the open-access status of Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis?

ScholarIQoa status

Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis has closed oa status in the ScholarIQ index.

What is the DOI of Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis?

ScholarIQdoi

The DOI for Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis is on the source record.

What is the PMID of Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis?

ScholarIQpmid

The PMID for Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis is on the source record.

What is the OpenAlex record for Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis?

ScholarIQopenalex

The OpenAlex for Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial